Launching of a first-in-class drug in a competitive market
We supported one client with the launch of first-in-class drug into competitive class in major disease area in Europe. Since the drug class was new, and there were other competitors emerging, our client wanted to know what the major concerns of prescribers were and what information they needed to decide to prescribe the product.
Real-time HCP tracking insights
As the product launched in several European markets, we tracked HCP information needs and channels preferences and identified:
Thanks to CREATION.co’s analysis, issues were identified and tactical and strategic recommendations were made to the client
Using our insights, the client was able to:
“We chose CREATION.co because of the value that their innovative tools and resources could provide us to enhance our data analytics approach to medical information. The findings from these projects have been impactful to the business and led to actionable insights.”
- A client in neuroscience in the US